Javad Jamshidi Fasa University of Medical Sciences, November 2015 Session 7 Medical Genetics...
-
Upload
timothy-milo-mcdowell -
Category
Documents
-
view
226 -
download
0
Transcript of Javad Jamshidi Fasa University of Medical Sciences, November 2015 Session 7 Medical Genetics...
Javad Jamshidi
Fasa University of Medical Sciences, November 2015
Session 7Medical Genetics
Hemoglobinopathies and Biochemical Genetics
At least 250,000 people are each year with disorders of hemoglobin (Hb), called Hemoglobinopathies
Hb is the protein present in red blood cells that is responsible for oxygen transport
Hb being made up of a tetramer consisting of two pairs of different polypeptides referred to as the α and β globin chains
16p13
11p15
1) Structural globin chain variants such as sickle cell disease
2) Disorders of synthesis of the globin chains such as the thalassemias
More than 300 Hb electrophoretic variants have been described due to a variety of types of mutation
The majority are rare and not associated with clinical disease
A few are associated with disease and relatively prevalent in certain populations.
The amino acid valine, at the sixth position of the β-globin chain, is substituted by glutamic acid.
The thalassemias are the commonest single group of inherited disorders in humans
Persons from the Mediterranean region, Middle East, Indian subcontinent, and Southeast Asia
The same pathophysiology, An imbalance of globin-chain production results in the accumulation of free globin chains in the red blood cell
α and β Thalassemia
Results from underproduction of the α-globin chains and occurs most commonly in Southeast Asia
Two main types of α-thalassemia:
The severe formNo α chains are produced, fetal deathHydrops fetalisTetramer of γ chains, called Hb Barts
The milder formSome α chains but still a relative excess of β chainsβ -globin tetramer Hb H-known as Hb H disease
Caused by underproduction of the β-globin chain of Hb.
Two main types of β-thalassemia:
The major formHomozygotes for β chains defect, Cooley's anemiaSevere transfusion-dependent anemiaAn unusually shaped face and skullAffected individuals used to die in their teens or early adulthood
The minor formHeterozygotes for β chains defectUsually have no symptoms or signs Mild hypochromic, microcytic anemia, may be confused with iron deficiency anemia.
Amino acid metabolism
Urea cycle
Carbohydrate metabolism
Steroid metabolism
Lipid metabolism
Lysosomal storage disorders
Disorders of purine/pyrimidine metabolism
Porphyrin metabolism
Copper metabolism
Peroxysomal disorders
Deficiency of the enzyme required for the conversion of phenylalanine to tyrosine, phenylalanine hydroxylase (PAH)
Children with phenylketonuria (PKU), if untreatedSeverely intellectually impaired Often develop seizuresOften have blond hair and blue eyes
Treatment by controlling phenylalanine diet intake
Maternal PKU
Block in the breakdown of homogentisic acid, a metabolite of tyrosine
Deficiency of the enzyme homogentisic acid oxidase
homogentisic acid accumulates and is excreted in the urine, which then darkens on exposure to air
Dark pigment is also deposited in certain tissues, such as, cartilage, and joints
Can lead to arthritis later in life.
Deficiency of the enzyme tyrosinase, which is necessary for the formation of melanin from tyrosine
Lack of pigment in the skin, hair, iris, and ocular fundusPoor visual acuity and uncontrolled pendular eye movements-nystagmus
OCA is genetically and biochemically heterogeneous.
OCA1, defective tyrosinase gene, tyrosinase-negative and positive forms, 11qOCA2, mutation in the P gene locates on 15qThere are some other loci
Galactosemia
Hereditary Fructose Intolerance
Deficiency of the enzyme galactose 1-phosphate uridyl transferase, necessary for the metabolism of galactose.
Newborns present with vomiting, lethargy, failure to thrive, and jaundice in the second week of life.
If untreated, they develop complications that include mental retardation, cataracts, and liver cirrhosis
Can be prevented by early diagnosis and feeding infants with milk substitutes that do not contain galactose or lactose
Autosomal recessive, resulting from a deficiency of the enzyme fructose 1-phosphate aldolase
Affected, present at different ages, depending on when fructose is introduced into the diet
Symptoms include failure to thrive, vomiting, jaundice, and seizures
Glycogen in muscle and liver, acting as a reserve energy source.
In GSDs glycogen accumulates in excessive amounts because of a variety of inborn errors of the enzymes
Primarily Affect Liver
Von Gierke Disease (GSD-I)Cori Disease (GSD-II)Anderson Disease (GSD-IV)Hepatic Phosphorylase Deficiency (GSD- VI)
Primarily Affect Muscle
Pompe Disease (GSD-II)McArdle Disease (GSD-V)
Primarily Affect Liver
Von Gierke Disease (GSD-I)Deficiency of the enzyme glucose-6-phosphataseEnlarged liver (hepatomegaly) and a fast heart rate due to hypoglycemiaTreatment is frequent feeding and avoidance of fasting
Primarily Affect Muscle
Pompe Disease (GSD-II)Deficiency of the lysosomal enzyme α-1,4-glucosidaseUsually present in the first few months of life with hypotonia Delay in the gross motor milestones because of muscle weaknessDevelop an enlarged heart and die from cardiac failure in the first or second year
The most common autosomal dominant single-gene disorder in Western society
Raised cholesterol levels with a significant risk of developing early coronary artery disease
Dietary restriction of cholesterol intake and drug treatment with 'statins' that reduce the endogenous synthesis of cholesterol
High cholesterol levels are due to deficient or defective function of the LDL receptors leading to increased levels of endogenous cholesterol synthesis.
Deficiency of a lysosomal enzyme involved in the degradation of complex macromolecules leads to their accumulation.
Children are usually normal initially but with the passage of time commence a downhill course
Hurler Syndrome (MPS-I)
Hunter Syndrome (MPS-II)
Sanfilippo Syndrome (MPS-III)
Morquio Syndrome (MPS-IV)
Maroteaux-lamy Syndrome (MPS-VI)
Sly Syndrome (MPS-VII)
Infants usually present by 6 months of age with poor feeding, lethargy, and floppiness.
Developmental regression in late infancy
Feeding becomes increasingly difficult
Progressively deteriorates
Deafness, visual impairment, and spasticity
Death usually occurs by the age of 3 years from respiratory
infection
Deficiency of the a subunit of the enzyme β-hexosaminidase that leads to accumulation of the sphingolipid GM2 ganglioside
Disorder of purine metabolism, XLR inheritance
Deficiency of hypoxanthine guanine phosphoribosyl transferase, increased levels of phosphoribosyl pyrophosphate.
An increased rate of purine synthesis and accumulation of uric acid
The main effect is neurological, with uncontrolled movements, spasticity, mental retardation and self-mutilation
XLR , Serum copper and ceruloplasmin levels are very low
The first few months of life with feeding difficulties, vomiting, and poor weight gain.
Subsequently, hypotonia, seizures, and progressive neurological and deterioration ensue,
death from recurrent respiratory infection usually occurring by the age of 3 years
Caused by mutation in an ATPase cation transport protein for copper
33
Myoclonic Epilepsy and Ragged Red Fiber Disease (MERRF)
Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes (MELAS)
Neurodegeneration, Ataxia, and Retinitis Pigmentosa (NARP)
Leigh Disease
Leber Hereditary Optic Neuropathy
Barth Syndrome